Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) shares, rose in value, with the stock price up by 0.65% to the previous day’s close as strong demand from buyers drove the stock to $61.74.
Actively observing the price movement in the last trading, the stock closed the session at $61.34, falling within a range of $60.925 and $61.96. The value of beta (5-year monthly) was 2.324. Referring to stock’s 52-week performance, its high was $68.58, and the low was $35.17. On the whole, RYTM has fluctuated by 11.83% over the past month.
With the market capitalization of Rhythm Pharmaceuticals Inc currently standing at about $3.90 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-25.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 183.48M, with a low estimate of 39M and a high estimate of 41.5M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 40.16M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RYTM’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of RYTM currently trading nearly 11.39% and 12.74% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 61.94, while the 7-day volatility ratio is showing 4.31% which for the 30-day chart, stands at 6.89%. Furthermore, Rhythm Pharmaceuticals Inc (RYTM)’s beta value is 2.25, and its average true range (ATR) is 3.66.
A comparison of Rhythm Pharmaceuticals Inc (RYTM) with its peers suggests the former has fared considerably weaker in the market. RYTM showed an intraday change of 0.65% in last session, and over the past year, it grew by 60.28%%.
Data on historical trading for Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) indicates that the trading volumes over the past 10 days have averaged 1.29 and over the past 3 months, they’ve averaged 640.44K. According to company’s latest data on outstanding shares, there are 62.39 million shares outstanding.
Nearly 9.93% of Rhythm Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 95.16% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.66 million shares as on 2025-03-31, resulting in a short ratio of 8.42. According to the data, the short interest in Rhythm Pharmaceuticals Inc (RYTM) stood at 1098.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 5.15 million. The stock has risen by 10.29% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RYTM stock heading into the next quarter.
